FindTrial
Sign In

Prospective Study Evaluating Aspirin Suppression of Intracranial Aneurysm Wall Inflammation with High-Resolution MR Imaging

Prospective Study Evaluating Aspirin Suppression of Intracranial Aneurysm Wall Inflammation with High-Resolution MR Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120504
Enrollment
Unknown
Registered
2026-03-16
Start date
2023-03-21
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysms

Interventions

Observation group:None

Sponsors

Banan District People's Hospital of Chongqing City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with unruptured intracranial aneurysms (UIAs) were recruited, with the inclusion criteria as follows: aged 18 to 80 years, of either sex, no contraindications to magnetic resonance imaging (MRI), and no planned surgical treatment for intracranial aneurysms (IAs) in the short term.

Exclusion criteria

Exclusion criteria: Exclusion criteria included contraindications to MRI, a history of previous aneurysmal rupture, concomitant arteriovenous malformation, fusiform or traumatic aneurysms, and intention to undergo endovascular or craniotomy treatment for intracranial aneurysms in the near term.

Design outcomes

Primary

MeasureTime frame
The enhancement ratio and wall-enhancement thickness of intracranial aneurysms;Wall-enhancement thickness of intracranial aneurysms;—

Countries

China

Contacts

Public ContactGuangxian Wang

Banan District People's Hospital of Chongqing City

wgxlove1234@163.com+86 136 4058 3247

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026